Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures

Clinical Cancer Research

Volumn 8, Issue 7, 2002, Pages 2292-2297

  Toyooka, Shinichi ^a   Fukuyama, Yasuro ^a   Wistuba, Ignacio I ^c   Tockman, Melvyn S ^d   Minna, John D ^a,b   Gazdar, Adi F ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; TRICHOSTATIN A; AZACITIDINE; DNA; DNA BINDING PROTEIN; DNA METHYLTRANSFERASE; DRUG DERIVATIVE; ENZYME INHIBITOR; HISTONE DEACETYLASE; HYDROXAMIC ACID; LZTS1 PROTEIN, HUMAN; MESSENGER RNA; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CHROMOSOME 8P; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; LUNG CANCER; LUNG NON SMALL CELL CANCER; MICROSATELLITE MARKER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE; ADENOCARCINOMA; CELL CULTURE; CHROMOSOME 8; CPG ISLAND; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; LARGE CELL CARCINOMA; LUNG TUMOR; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ADENOCARCINOMA; AZACITIDINE; BLOTTING, WESTERN; CARCINOMA, LARGE CELL; CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 8; CPG ISLANDS; DNA MODIFICATION METHYLASES; DNA, NEOPLASM; DNA-BINDING PROTEINS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HISTONE DEACETYLASES; HUMAN; HYDROXAMIC ACIDS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED; HUMANS; TUMOR SUPPRESSOR PROTEINS;

EID: 0035992406     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Cancer statistics, 2000
2. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types
3. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering
4. Progress in understanding the molecular pathogenesis of human lung cancer
5. Molecular changes in the bronchial epithelium of patients with small cell lung cancer
6. Fine deletion mapping of chromosome 8p in non-small-cell lung carcinoma
7. Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer
8. Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma
9. Deletion mapping of the short arm of chromosome 8 in non-small cell lung carcinoma
10. Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes
11. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer
12. Loss of heterozygosity and linkage analysis in breast carcinoma: Indication for a putative third susceptibility gene on the short arm of chromosome 8
13. Deletion mapping reveals two regions of chromosome 8 allele loss in colorectal carcinomas
14. Loss of heterozygosity from the short arm of chromosome 8 is an early event in breast cancers
15. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer
16. Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma
17. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms
18. Loss of chromosome arm 8p loci in prostate cancer: Mapping by quantitative allelic imbalance
19. Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP)
20. Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer
21. Allelic loss in human intrahepatic cholangiocarcinoma: Correlation between chromosome 8p22 and tumor progression
22. Functional evidence for a colorectal cancer tumor suppressor gene at chromosome 8p22-23 by monochromosome transfer
23. Suppression of metastasis of rat prostatic cancer by introducing human chromosome 8
24. Suppression of invasive ability of highly metastatic rat prostate cancer by introduction of human chromosome 8
25. Mapping of metastasis suppressor gene(s) for rat prostate cancer on the short arm of human chromosome 8 by irradiated microcell-mediated chromosome transfer
26. Isolation of a candidate tumor suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain of the PDGF receptor β gene
27. The FEZI gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors
28. Fez1/lzts1 alterations in gastric carcinoma
29. Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer
30. Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells
31. Isolation of genomic DNA
32. FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis
33. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers
34. DNA methylation profiles of lung tumors
35. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
36. Different pattern of expression of cellular oncogenes in human non- small-cell lung cancer cell lines
37. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines
38. Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines
39. Differential inactivation of caspase-8 in lung cancers